在动脉样硬化心血管疾病中的精准医学:从Omics数据对性别差异的洞察力
Jelena Munjas1, Sandra Vladimirov1, Tamara Ratkovic1
1Department of Medical Biochemistry, Faculty of Pharmacy, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia.
动脉样硬化心血管疾病 (ASCVD) 的性别差异是由复杂的生物相互作用驱动的. 多组学研究为个性化预防和治疗策略提供了潜力,但需要克服分析挑战.
科学领域:
- 心血管医学 心血管医学
- 基因组学就是基因组学.
- 精准医学是一门精准的医学.
背景情况:
- 动脉样性心血管疾病 (ASCVD) 是一个主要的全球健康问题.
- 在ASCVD流行病学和发病过程中认可的性别差异需要更深入的生物学理解.
- 女性表现出明显的ASCVD表型,包括纤维状斑块和微血管功能障碍.
研究的目的:
- 审查奥米克研究,澄清性别特异性ASCVD模式的分子机制.
- 探索对精确心血管医学的影响.
- 确定性别特定的监管网络和治疗点.
主要方法:
- 审查最近的基因组学,表观基因组学,转录基因组学,蛋白质组学和代谢组学方面的进展.
- 综合多组学数据来剖析性别特异的ASCVD机制.
- 分析数据整合,协调和计算需求的挑战.
主要成果:
- 在ASCVD中,性别差异是由于复杂的荷尔蒙,遗传,表观遗传和分子相互作用造成的.
- 奥米克斯方法揭示了发现性别特异性监管网络和治疗点的潜力.
- 多种经济学技术为精细的个性化风险分层和处理提供了机会.
结论:
- 对于理解性别特异性ASCVD机制和推进精确心血管医学而言,多组学研究至关重要.
- 克服分析和基础设施障碍对于实现多元经济的全部潜力至关重要.
- 标准化的方法和协作努力将改善ASCVD的预防和治疗.
更多相关视频
08:21Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
相关概念视频
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Genomics
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
